Eagle Pharmaceuticals, Inc. EGRX OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

Eagle Pharmaceuticals, Inc. (EGRX) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 2 Buy, 3 Hold, 1 Sell.

EGRX Analyst Ratings

Hold

Ratings

2 Buy

3 Hold

1 Sell

Based on 6 analysts giving stock ratings to Eagle Pharmaceuticals, Inc. in the past 3 months

Rating breakdown

Buy

2 33%

Hold

3 50%

Sell

1 17%

33%

Buy

2 analysts

50%

Hold

3 analysts

17%

Sell

1 analysts

People Also View

RGC

Regencell Bioscience Holdings Limited

Prestige Consumer Healthcare Inc.

$57.57

+1.61%

PAHC

Phibro Animal Health Corporation

$55.01

-6.79%

DCPH

Deciphera Pharmaceuticals, Inc.

$25.59

+0.08%

ANIP

ANI Pharmaceuticals, Inc.

$76.48

-2.31%

COLL

Collegium Pharmaceutical, Inc.

$34.93

-1.99%

AMPH

Amphastar Pharmaceuticals, Inc.

$21.68

+1.40%

Eagle Pharmaceuticals, Inc. EGRX OTC

EGRX Analyst Ratings

People Also View

Get Undervalued Stock Alerts